Please login to the form below

Not currently logged in
Email:
Password:

New EC health director general takes office

XavierPrats Monné will report to health commissioner Dr Vytenis Andriukaitis

European Commission DG Sante Xavier Prats MonnéThe European Commission's health and food safety directorate has a new director general, with Xavier Prats Monné taking over from acting director-general Miko Ladislav.

There has not been a permanent director general for DG Sante, as the directorate is known, since a breach of tender procedure saw Paola Testori Coggi step down after she alerted an NGO to the timing of a food-related study.

In his new role Prats Monné will report to the commissioner responsible for health Dr Vytenis Andriukaitis.

Prats Monné was previously director general for education and culture, a post he held since 2014 - prior to which he spent three years as deputy director general with responsibility for EU policies on education and training.

A Spanish national, he has also served for the European Social Fund (ESF), as deputy head of cabinet of the commission vice president for international relations, and as an assistant European Commission spokesman under president Jacques Delors.

Prats Monné's appointment was part of a reshuffle of the Commission's senior management by president Jean-Claude Juncker and, in a statement, the EC said the changes were a “further step in gearing the Commission towards effective delivery”.

Previously known as DG Sanco, DG Sante aims to make Europe a healthier, safer place and has 960 staff - around 660 based in Brussels (home to its pharmaceuticals unit), 120 in Luxembourg and another 180 in Grange, near Dublin.

9th September 2015

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...